Mechanistic Studies of Nicotinamide Riboside in Human Heart Failure

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT04528004

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:26:42.079872+00:00

Published At

2025-03-25T00:00:00+00:00

Record Updated At

2025-03-25

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Heart Failure, Systolic", "Heart Failure NYHA Class IV", "Metabolic Disturbance"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2025-03-25"

protocolSection.identificationModule.nctId

"NCT04528004"

protocolSection.identificationModule.officialTitle

"Mechanistic Studies of Nicotinamide Riboside in Human Heart Failure"

protocolSection.statusModule.overallStatus

"ACTIVE_NOT_RECRUITING"

protocolSection.designModule.phases

["EARLY_PHASE1"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Heart Failure, Systolic (protocolSection.conditionsModule.conditions)
• Heart Failure NYHA Class IV (protocolSection.conditionsModule.conditions)
• Metabolic Disturbance (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.